EXCLUSIVE | Three Firms To Bring Cheaper Key TB Drug To India Soon As J&J Patent Expires
[ad_1] Johnson & Johnson’s global patent on bedaquiline, considered to be one of the most effective treatments available for tuberculosis, expired last month, paving the way for this life-saving drug to get cheaper across the world. Three Indian firms are already set to bring cheaper versions of the drug to the market soon. With J&J’s … Read more